Florian Lordick, MD, on Gastric Cancer: Final Results From the AIO Trial

2018 Gastrointestinal Cancers Symposium
Tweet this page

Florian Lordick, MD, of the University Medicine Leipzig, discusses study findings on intraperitoneal immunotherapy with the antibody catumaxomab for patients with peritoneal carcinomatosis from gastric cancer (Abstract 4).

Advertisement

Advertisement

Advertisement